Skip to Main Content

Paper Details

Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.
Nat Med
53
2020
CD8+ T cell dysfunction, MDK, Midkine, PD-1, PD-L1, aggressive, anti-, cancers, interferon, macrophages, malignant cells, melanoma, melanoma cells, melanomas, midkine, nuclear factor-B, patient, tumors
Author NameAffiliation
Andrew X ChenColumbia University College of Physicians and Surgeons
Osvaldo Gra??aSpanish National Cancer Research Centre (CNIO)
F??tima Al-ShahrourSpanish National Cancer Research Centre (CNIO)
Raul RabadanColumbia University College of Physicians and Surgeons
Mitchell P LevesqueUniversity of Zurich Hospital
Mitchell P LevesqueUniversity of Zurich Hospital
  • 1 - 6

Datasets

Release 1.2